Prognostic factors for multiple sclerosis: the importance of natural history studies
- PMID: 16170495
- DOI: 10.1007/s00415-005-2012-4
Prognostic factors for multiple sclerosis: the importance of natural history studies
Abstract
Detailed studies of the natural history of untreated multiple sclerosis (MS) have been carried out in London, Ontario, Canada, over the past generation. There are now some 25,000 patient-years of follow-up in a cohort of slightly more than 1,000 individuals. From the data, it is clear that a number of factors are associated with long-term outcome of the disease. The Ontario database reveals several prognostic variables that are clinical in nature, which can be used to evaluate prognosis in any clinical subtype. The most important factors include the development of a progressive deficit and time to onset of progressive deficit. In addition, and independently, a high number of relapses in the first and second year is associated with poor long-term outcome, as is the development of early unremitting disability. An important question is whether or not primary-progressive (PP) MS represents an independent entity separate from secondary-progressive (SP) MS. No specific category of PP disease is distinguishable from SP disease using available clinical measures. There is reason to believe that magnetic resonance imaging (MRI) activity (when appropriately controlled for other unequally distributed factors, such as age) will be found to be very similar.
Similar articles
-
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.Brain. 1999 Apr;122 ( Pt 4):625-39. doi: 10.1093/brain/122.4.625. Brain. 1999. PMID: 10219776
-
Natural history of multiple sclerosis: a unifying concept.Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16. Brain. 2006. PMID: 16415308
-
Early relapses, onset of progression, and late outcome in multiple sclerosis.JAMA Neurol. 2013 Feb;70(2):214-22. doi: 10.1001/jamaneurol.2013.599. JAMA Neurol. 2013. PMID: 23407713
-
Clinical prognostic factors in multiple sclerosis: a natural history review.Nat Rev Neurol. 2009 Dec;5(12):672-82. doi: 10.1038/nrneurol.2009.178. Nat Rev Neurol. 2009. PMID: 19953117 Review.
-
Natural history of multiple sclerosis: risk factors and prognostic indicators.Curr Opin Neurol. 2007 Jun;20(3):269-74. doi: 10.1097/WCO.0b013e32812583ad. Curr Opin Neurol. 2007. PMID: 17495619 Review.
Cited by
-
Evidence for a two-stage disability progression in multiple sclerosis.Brain. 2010 Jul;133(Pt 7):1900-13. doi: 10.1093/brain/awq076. Epub 2010 Apr 27. Brain. 2010. PMID: 20423930 Free PMC article.
-
Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France.J Neurol. 2007 Oct;254(10):1370-5. doi: 10.1007/s00415-007-0554-3. Epub 2007 Jun 25. J Neurol. 2007. PMID: 17579804
-
Combination of Probiotics and Natural Compounds to Treat Multiple Sclerosis via Warburg Effect.Adv Pharm Bull. 2022 May;12(3):515-523. doi: 10.34172/apb.2022.057. Epub 2021 Sep 29. Adv Pharm Bull. 2022. PMID: 35935051 Free PMC article. Review.
-
Preserved decision making ability in early multiple sclerosis.J Neurol. 2008 Nov;255(11):1762-9. doi: 10.1007/s00415-008-0025-5. Epub 2008 Nov 13. J Neurol. 2008. PMID: 19009335
-
Estimating typical multiple sclerosis disability progression speed from clinical observations.PLoS One. 2014 Oct 17;9(10):e105123. doi: 10.1371/journal.pone.0105123. eCollection 2014. PLoS One. 2014. PMID: 25329469 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous